On this page
- Leadership changes at Bravo Multinational Inc. (2026)
- Leadership changes at Caesars Entertainment, Inc. (2026)
- Leadership changes at Domo, Inc. (2026)
- Leadership changes at HCA Healthcare, Inc. (2026)
- Leadership changes at Incyte Corp (2026)
- Leadership changes at Match Group, Inc. (2026)
- Leadership changes at Nextdoor Holdings, Inc. (2026)
- Leadership changes at Onfolio Holdings, Inc (2026)
- Leadership changes at Option Care Health, Inc. (2026)
- Leadership changes at Starling Oncology, Inc. (2026)
- Leadership changes at Sunstone Hotel Investors, Inc. (2026)
- Leadership changes at Versus Systems Inc. (2026)
Leadership changes at Bravo Multinational Inc. (2026)
Bravo Multinational Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-12. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Bravo Multinational Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 6, 2026 | Stake report, Schedule 13D, by Michael Williams | 78.24% of the class | 5%+ stakes | Source |
| October 6, 2026 | Stake report, Schedule 13D/A, by WTFJ Investments, LLC | 59.4% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-12 | Out | Kayla Slick | Director | 8-K, 2026-08-12 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Kayla Slick, departure reported (filed 2026-08-12). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Bravo Multinational Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Bravo Multinational Inc., with the record behind each one.
Find candidates like Director at Bravo Multinational Inc.Departure Of Director Or Certain Officer On August 7, 2026, at a board of directors meeting on that date, Ms. Kayla Slick resigned her positions as an officer and director of Bravo Multinational, Inc. (the "Company").
- Ms. Slick's decision to resign was not the result of any dispute or disagreements with the Company on any matter relating to the Company's operation, policies (including accounting or financial policies) or practices.
Leadership changes at Caesars Entertainment, Inc. (2026)
Caesars Entertainment, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-07-08 to 2026-09-17. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Caesars Entertainment, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G, by Pentwater Capital Management LP | 5.6% of the class | 5%+ stakes | Source |
| August 12, 2026 | Stake report, Schedule 13G/A, by Capital World Investors | — | 5%+ stakes | Source |
| June 5, 2026 | Stake report, Schedule 13G/A, by Cohen & Steers, Inc. | 2.33% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Cohen & Steers, Inc. | 6.02% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.08% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.1% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by Capital Research Global Investors | 4.9% of the class | 5%+ stakes | Source |
| December 4, 2025 | Stake report, Schedule 13G, by BlackRock, Inc. | 11.5% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by Capital Research Global Investors | 7.4% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by Capital World Investors | 7.8% of the class | 5%+ stakes | Source |
| October 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 4.4% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-17 | Reported | not named in the filing | 8-K, 2026-09-17 | ||
| 2026-07-08 | Out | Courtney Mather | Executive Chairman | 2026-07-06 | 8-K, 2026-07-08 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Executive Chairman: Courtney Mather, departure reported, effective 2026-07-06 (filed 2026-07-08). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Caesars Entertainment, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Executive Chairman at Caesars Entertainment, Inc., with the record behind each one.
Find candidates like Executive Chairman at Caesars Entertainment, Inc.On September 16, 2026, Jesse Lynn and Ted Papapostolou informed the Executive Chairman of the Board of Directors (the " Board ") of Caesars Entertainment, Inc., a Delaware corporation (the " Company "), that they have decided to resign from the Board effective immediately.
- The Icahn Group also waived their right to appoint replacement directors under the Director Appointment and Nomination Agreement, dated March 17, 2025.
On July 6, 2026, Courtney Mather informed the Executive Chairman of the Board of Directors (the "Board") of Caesars Entertainment, Inc., a Delaware corporation (the "Company"), that he has decided to resign from the Board effective July 6, 2026.
- Mr. Mather's resignation is not the result of any disagreement with the Company.
Leadership changes at Domo, Inc. (2026)
Domo, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-26. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Domo, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 19, 2026 | Stake report, Schedule 13G/A, by Orin Hirschman | — | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by G1 Execution Services, LLC | 5.2% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by Kenneth Griffin | 5.7% of the class | 5%+ stakes | Source |
| July 27, 2026 | Stake report, Schedule 13G, by Orin Hirschman | 6.9% of the class | 5%+ stakes | Source |
| July 8, 2026 | Stake report, Schedule 13G/A, by BlackRock Portfolio Management LLC | 11.5% of the class | 5%+ stakes | Source |
| June 18, 2026 | Stake report, Schedule 13D/A, by RPD Fund Management LLC | 0.63% of the class | 5%+ stakes | Source |
| June 3, 2026 | Stake report, Schedule 13D/A, by RPD Fund Management LLC | 9.87% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Portolan Capital Management, LLC | 0.47% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by Capital Research Global Investors | — | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 8.43% of the class | 5%+ stakes | Source |
| April 8, 2026 | Stake report, Schedule 13G/A, by Ameriprise Financial, Inc. | — | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
The newest 12 of 25 records.
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-26 | Out | Daren Thayne | Chief Technology Officer | 2026-07-10 | 8-K, 2026-06-26 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Technology Officer: Daren Thayne, departure reported, effective 2026-07-10 (filed 2026-06-26). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Domo, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Technology Officer at Domo, Inc., with the record behind each one.
Find candidates like Chief Technology Officer at Domo, Inc.On June 22, 2026, Daren Thayne, Chief Technology Officer and Executive Vice President of Product of Domo, Inc. (the "Company" or "Domo"), notified the Company of his decision to resign, effective July 10, 2026 (the "Effective Date"), to accept another executive position outside the Company.
- Mr. Thayne's resignation is not the result of any disagreements with the Company on any matter relating to the Company's operations, policies, or practices.
- Mr. Thayne is expected to remain in his current position to assist with the transition of his responsibilities through the Effective Date.
- In light of advanced negotiations around a potential transaction involving Domo, the Company does not immediately plan to replace Mr. Thayne and his duties will be assumed, on an interim basis, by other members of management.
Leadership changes at HCA Healthcare, Inc. (2026)
HCA Healthcare, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-18. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as HCA Healthcare, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 6, 2026 | Stake report, Schedule 13D/A, by Frisco Holding II | 33.8% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.25% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 10, 2026 | Stake report, Schedule 13D, by Frisco Holding II | 31.6% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-18 | Out | Michael Cuffe | Chief Clinical Officer | 2026-08-31 | 8-K, 2026-06-18 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Clinical Officer: Michael Cuffe, departure reported, effective 2026-08-31 (filed 2026-06-18). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on HCA Healthcare, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Clinical Officer at HCA Healthcare, Inc., with the record behind each one.
Find candidates like Chief Clinical Officer at HCA Healthcare, Inc.On June 15, 2026, Dr. Michael Cuffe and HCA Healthcare, Inc. (the "Company") agreed that Dr. Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and thereafter continue in a transitional role with the Company until February 2027.
- Dr. Cuffe will be eligible to receive benefits according to the Company's executive severance policy and applicable incentive plans.
Leadership changes at Incyte Corp (2026)
Incyte Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-30. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Incyte Corp files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 14, 2026 | Stake report, Schedule 13G/A, by Dodge & Cox | 6.2% of the class | 5%+ stakes | Source |
| May 11, 2026 | Stake report, Schedule 13D/A, by Baker Bros. Advisors LP | 15.6% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 6.32% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 10, 2026 | Stake report, Schedule 13D/A, by Baker Bros. Advisors LP | 15.7% of the class | 5%+ stakes | Source |
| November 10, 2025 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5% of the class | 5%+ stakes | Source |
| October 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 7.8% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-30 | Out | Susanne Schaffert | 2026-04-15 | 8-K, 2026-03-30 |
New leaders reset buying decisions — get the Full Report on Incyte Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Incyte Corp, with the record behind each one.
Find candidates like senior executive at Incyte CorpOn March 26, 2026, Susanne Schaffert notified Incyte Corporation (the "Company") that she was resigning from the Company's Board of Directors (the "Board"), effective as of April 15, 2026.
- The resignation of Dr. Schaffert, who has been a member of the Company's Board since 2022, was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Leadership changes at Match Group, Inc. (2026)
Match Group, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-04-30. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Match Group, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by Ameriprise Financial, Inc. | 8.2% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Ameriprise Financial, Inc. | 5.7% of the class | 5%+ stakes | Source |
| May 12, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 3.6% of the class | 5%+ stakes | Source |
| May 6, 2026 | Stake report, Schedule 13D/A, by Starboard Value LP | 4.6% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.26% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 6.37% of the class | 5%+ stakes | Source |
| April 7, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 11.9% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 9, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 6.9% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Ameriprise Financial, Inc. | 4.4% of the class | 5%+ stakes | Source |
| November 10, 2025 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 8% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G, by Ameriprise Financial, Inc. | 5.1% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-04-30 | In | Raina Moskowitz | 8-K, 2026-04-30 |
New leaders reset buying decisions — get the Full Report on Match Group, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Match Group, Inc., with the record behind each one.
Find candidates like senior executive at Match Group, Inc.On April 29, 2026, the Board of Directors (the "Board") of Match Group, Inc. (the "Company") appointed Raina Moskowitz to the Board, effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), with a term expiring at the Company's 2027 annual meeting of stockholders (the "2027 Annual Meeting").
- Ms. Moskowitz's appointment fills the vacancy resulting from the previously announced resignation by Pamela S. Seymon as a member of the Board, which is also effective as of the 2026 Annual Meeting.
- The Board has not yet determined which, if any, committees Ms. Moskowitz will be appointed to serve as a member.
- As previously announced by the Company on February 17, 2026, Manuel Bronstein will stand for election to the Board at the 2026 Annual Meeting for a term that expires at the 2027 Annual Meeting.
Leadership changes at Nextdoor Holdings, Inc. (2026)
Nextdoor Holdings, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-25. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Nextdoor Holdings, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by Amova Asset Management Americas, Inc. | 4.9% of the class | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G/A, by Sumitomo Mitsui Trust Group, Inc. | 4.9% of the class | 5%+ stakes | Source |
| January 30, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | 5.53% of the class | 5%+ stakes | Source |
| January 21, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 6.5% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G, by Amova Asset Management Americas, Inc. | 5.7% of the class | 5%+ stakes | Source |
| October 27, 2025 | Stake report, Schedule 13G, by Sumitomo Mitsui Trust Group, Inc. | 5.7% of the class | 5%+ stakes | Source |
| July 29, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 6.75% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-25 | Out | Craig Lisowski | President | 2026-10-16 | 8-K, 2026-09-25 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President: Craig Lisowski, departure reported, effective 2026-10-16 (filed 2026-09-25). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Nextdoor Holdings, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President at Nextdoor Holdings, Inc., with the record behind each one.
Find candidates like President at Nextdoor Holdings, Inc.On September 21, 2026, Craig Lisowski resigned from his position as the President of Products of Nextdoor Holdings, Inc. (the "Company"), effective October 16, 2026.
- Mr. Lisowski's resignation is not the result of any disagreement regarding the Company's operations, policies or practices.
Leadership changes at Onfolio Holdings, Inc (2026)
Onfolio Holdings, Inc reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-01. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Onfolio Holdings, Inc files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 5, 2026 | Stake report, Schedule 13G/A, by Alta Partners LLC | 0.5% of the class | 5%+ stakes | Source |
| June 10, 2026 | Stake report, Schedule 13G/A, by ARBERMAN JOEL | 5% of the class | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by Wells Dominic Benjamin James | 27% of the class | 5%+ stakes | Source |
| February 11, 2026 | Stake report, Schedule 13G, by ATW Digital Assets XI LLC | 9.9% of the class | 5%+ stakes | Source |
| November 18, 2025 | Stake report, Schedule 13G/A, by Alta Partners LLC | 9.7% of the class | 5%+ stakes | Source |
| October 24, 2025 | Form D, private offering | $1M sold | Form D page | Source |
| October 16, 2025 | Stake report, Schedule 13G, by Alta Partners LLC | 11% of the class | 5%+ stakes | Source |
| September 16, 2025 | Stake report, Schedule 13G/A, by ARBERMAN JOEL | 9.3% of the class | 5%+ stakes | Source |
| January 29, 2025 | Form D, private offering | — | Form D page | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-01 | Out | Robert Lipstein | Director | 2026-05-31 | 8-K, 2026-05-01 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Robert Lipstein, departure reported, effective 2026-05-31 (filed 2026-05-01). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Onfolio Holdings, Inc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Onfolio Holdings, Inc, with the record behind each one.
Find candidates like Director at Onfolio Holdings, IncOn April 27, 2026, Robert Lipstein notified the Onfolio Holdings Inc. (the "Company") Chair of the Board that he intended to resign as a director of the Company effective May 31, 2026.
- Mr. Lipstein's resignation is not a result of any disagreement between himself and the Company, its management, the Board of Directors (the "Board") or any committee of the Board.
Leadership changes at Option Care Health, Inc. (2026)
Option Care Health, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-05. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Option Care Health, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 13.1% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Durable Capital Partners LP | 3.9% of the class | 5%+ stakes | Source |
| May 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 4.1% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.25% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.24% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| November 5, 2025 | Stake report, Schedule 13G, by FMR LLC | 5.3% of the class | 5%+ stakes | Source |
| August 12, 2025 | Stake report, Schedule 13G/A, by Wellington Management Group LLP | 8.1% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-05 | Out | Christopher L. Grashoff | Chief Growth Officer | 2026-05-08 | 8-K, 2026-05-05 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Growth Officer: Christopher L. Grashoff, departure reported, effective 2026-05-08 (filed 2026-05-05). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Option Care Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Growth Officer at Option Care Health, Inc., with the record behind each one.
Find candidates like Chief Growth Officer at Option Care Health, Inc.On May 5, 2026, Option Care Health, Inc. (the "Company") announced that Christopher L. Grashoff will depart from his role as Chief Growth Officer of the Company, effective May 8, 2026.
- Mr. Grashoff will be entitled to separation benefits consistent with the Company's Amended and Restated Executive Severance Plan, which are conditioned upon the effectiveness of a general release of claims in favor of the Company and Mr. Grashoff's continued compliance with restrictive covenants.
Leadership changes at Starling Oncology, Inc. (2026)
Starling Oncology, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-02. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Starling Oncology, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 15, 2026 | Stake report, Schedule 13D/A, by M33 Growth I L.P. | 4.94% of the class | 5%+ stakes | Source |
| March 16, 2026 | Stake report, Schedule 13G/A, by Chernett Jorey | 10.2% of the class | 5%+ stakes | Source |
| January 15, 2026 | Stake report, Schedule 13G, by Chernett Jorey | 5.2% of the class | 5%+ stakes | Source |
| November 20, 2025 | Stake report, Schedule 13D/A, by M33 Growth I LP | 5.46% of the class | 5%+ stakes | Source |
| September 5, 2025 | Stake report, Schedule 13D/A, by M33 Growth I LP | 9.79% of the class | 5%+ stakes | Source |
| April 8, 2025 | Form D, private offering | $16.44M sold | Form D page | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-02 | Out | Brad Hively | 8-K, 2026-09-02 |
New leaders reset buying decisions — get the Full Report on Starling Oncology, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Starling Oncology, Inc., with the record behind each one.
Find candidates like senior executive at Starling Oncology, Inc.On September 1, 2026, Brad Hively notified Starling Oncology, Inc. (the "Company") of his decision to not stand for re-election to the Board of the Directors of the Company (the "Board") at its 2027 annual meeting of stockholders (the "Annual Meeting").
- Mr. Hively is expected to continue to serve as a director of the Company until the Annual Meeting, but effective immediately, will no longer serve as Vice Chairman of the Board or as a member of the Compliance Committee or any other committees of the Board.
- Mr. Hively's decision not to stand for re-election is not the result of any disagreement between the Company and him on any matter relating to Company's operations, policies or practices.
Leadership changes at Sunstone Hotel Investors, Inc. (2026)
Sunstone Hotel Investors, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-05. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Sunstone Hotel Investors, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 30, 2026 | Stake report, Schedule 13G/A, by Vanguard Portfolio Management | 11.33% of the class | 5%+ stakes | Source |
| August 6, 2026 | Stake report, Schedule 13G/A, by BANK OF AMERICA CORP /DE/ | 3.4% of the class | 5%+ stakes | Source |
| August 3, 2026 | Stake report, Schedule 13G/A, by BANK OF AMERICA CORP /DE/ | 3.4% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G, by BANK OF AMERICA CORP /DE/ | 5.3% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.34% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 10.22% of the class | 5%+ stakes | Source |
| July 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 17% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-05 | Out | David Klein | General Counsel | 2026-05-31 | 8-K, 2026-05-05 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- General Counsel: David Klein, departure reported, effective 2026-05-31 (filed 2026-05-05). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Sunstone Hotel Investors, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the General Counsel at Sunstone Hotel Investors, Inc., with the record behind each one.
Find candidates like General Counsel at Sunstone Hotel Investors, Inc.As a result, David Klein will depart from his position as General Counsel and Secretary of the Company, effective May 31, 2026.
- Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
- In connection with the restructuring by Sunstone Hotel Investors, Inc. of its executive team, the Company has determined to eliminate the position of General Counsel from its management structure.
- Prior to the termination date, Mr. Klein will continue to provide services in his current position with the Company, including transition assistance in connection with his departure.
- Following his departure, Mr. Klein has agreed to reasonably cooperate with and assist the Company with respect to proceedings with which he was involved prior to his departure.
Leadership changes at Versus Systems Inc. (2026)
Versus Systems Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-10. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Versus Systems Inc. files it.
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-10 | In | Brian Goldenberg | Chief Financial Officer | 8-K, 2026-09-10 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Brian Goldenberg, appointed (filed 2026-09-10).
New leaders reset buying decisions — get the Full Report on Versus Systems Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at Versus Systems Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Versus Systems Inc.On September 8, 2026, Versus Systems, Inc. (the "Company") appointed Brian Goldenberg to serve as the Company's Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer.
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory.
- From November 2023 to February 2026, Mr. Goldenberg served as Chief Operating Officer, Chief Compliance Officer, and Chief Financial Officer of Divisadero Street Capital Management, Miami, Florida.
- From February 2018 to November 2023, he served as Chief Financial Officer of Trend Capital Management, Boca Raton, Florida.
- In connection with Mr. Goldenberg's appointment, Company President and Chief Executive Officer Luis Goldner will no longer serve as the Company's Principal Financial Officer.